packerfan9
4 días hace
8.5 billion new shares to be issued. I told people they never stop diluting and the buyback was a lie. Every day shares sold is dilution and that never changes. This will be at .0001 even sooner to sell all these.
CBD Life Sciences, Inc.
8,400,000,000 Shares of Common Stock
This Post-Qualification Offering Circular Amendment No. 3 amends the Offering Circular of CBD Life Sciences, Inc., a Nevada corporation (the “Company”), dated June 24, 2024, as qualified on June 21, 2024, and Post-Qualification Amendment No. 2 as filed on September 6, 2024, as qualified on September 17, 2024, and as may be amended and supplemented from time to time, to: (a) extend the expiration date of this offering to February 28, 2026; (b) to add 3,900,000,000 additional shares of common stock to the offered by this Offering Circular, for a revised maximum of 8,400,000,000 shares (collectively, the “Offered Shares”); and (c) to revise the offering price of the 6,687,062,556 shares of Company common stock that remain unsold (the “Remaining Shares”) to $__[0.0001-0.0006].
By this Offering Circular, the Company is offering for sale a maximum of 8,500,000,000 shares of its common stock (the Offered Shares), of which 1,478,666,729 shares have been sold for cash in the total amount of $696,310 and of which 6,687,062,556 shares, the Remaining Shares, at a fixed price of $__[0.0001-0.0006] per share, pursuant to Tier 1 of Regulation A of the United States Securities and Exchange Commission (the “SEC”). A minimum purchase of $5,000 of the Offered Shares is required in this offering; any additional purchase must be in an amount of at least $1,000. This offering is being conducted on a best-efforts basis, which means that there is no minimum number of Offered Shares that must be sold by us for this offering to close; thus, we may receive no or minimal proceeds from this offering. All proceeds from this offering will become immediately available to us and may be used as they are accepted. Purchasers of the Offered Shares will not be entitled to a refund and could lose their entire investments.
Chartmaster
2 semanas hace
BD Life Sciences Inc. (CBDL) Launches Mushroom Powder CapsulesPress Release | 02/26/2025
The Global Functional Mushroom Market is Set to Surpass $19 Billion by 2030—CBDL Enters the Booming Industry with Premium Mushroom Capsules for Cognitive Enhancement, Immune Support & Longevity!
SCOTTSDALE, ARIZONA / ACCESSWIRE / February 26, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL) is making a bold move into the multi-billion-dollar functional mushroom market with the official launch of its Mushroom Powder Capsules-a powerful, all-natural supplement designed to elevate brain function, enhance energy, boost immunity, and optimize overall wellness.
This premium formulation combines five of the most researched and revered medicinal mushrooms:
Lion's Mane - Known for its neuroprotective properties, enhances cognitive function, memory, and focus.
Cordyceps - Increases stamina, improves athletic performance, and supports lung function.
Reishi - Helps reduce stress, promotes better sleep, and strengthens the immune system.
Maitake - Supports metabolic health and helps regulate blood sugar levels.
Turkey Tail - Packed with antioxidants and polysaccharides that fortify gut health and boost immunity.
With scientific studies confirming the vast health benefits of these mushrooms, CBDL is positioning itself at the forefront of the natural health revolution. The global demand for functional mushrooms has skyrocketed due to their ability to combat stress, enhance brain power, and promote longevity-aligning perfectly with consumer trends toward holistic wellness and plant-based supplementation.
A Massive Revenue Opportunity
By launching into the functional mushroom industry, CBDL is tapping into a market projected to exceed $19 billion by 2030, with a CAGR of 9.1%. This strategic expansion will drive substantial new revenue streams and significantly increase consumer engagement with the brand.
CBDL's Mushroom Powder Capsules will be available through its existing sales channels, including direct-to-consumer e-commerce and select retail partners, with further distribution expansion planned as demand grows.
"This launch marks a pivotal moment for CBDL as we expand beyond CBD and into the booming functional mushroom sector," said Lisa Nelson, CEO of CBD Life Sciences Inc. "Our goal is to provide top-tier, science-backed natural solutions that enhance everyday health while capitalizing on one of the fastest-growing wellness trends in the world."
CBDL is committed to aggressive marketing, expanding its direct sales reach, and forming strategic partnerships to position its Mushroom Powder Capsules as a category leader. With consumer interest surging and scientific validation mounting, CBDL's foray into functional mushrooms represents not just an innovative product launch-but a major step toward long-term profitability and market dominance.
About CBD Life Sciences Inc.
CBD Life Sciences Inc. (OTC:CBDL) is a leading innovator in the CBD and natural health industry, dedicated to developing high-quality, science-backed products that enhance wellness and vitality. With a growing portfolio spanning CBD topicals, edibles, and now functional mushrooms, CBDL continues to push boundaries in holistic health solutions.
For more information about CBD Life Sciences, Inc. and its product offerings, visit www.thecbdvault.com
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com
Stay Connected & Be the First to Try Our New Functional Mushroom Products!
Mushroom Madness Instagram: https://www.instagram.com/mushroom.madnessaz
Mushroom Madness Website: https://www.mushroommadness.shop
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contact Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720
SOURCE: CBD Life Sciences, Inc.
View the original press release on accesswire.com
https://www.otcmarkets.com/stock/CBDL/news/CBD-Life-Sciences-Inc-CBDL-Launches-Mushroom-Powder-Capsules?id=468863
AveragePenny
2 semanas hace
$CBDL CBD Life Sciences Inc. (CBDL) Launches Mushroom Powder Capsules
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cbd-life-sciences-inc-cbdl-launches-mushroom-powder-capsules-991624
The Global Functional Mushroom Market is Set to Surpass $19 Billion by 2030—CBDL Enters the Booming Industry with Premium Mushroom Capsules for Cognitive Enhancement, Immune Support & Longevity!
SCOTTSDALE, ARIZONA / ACCESS Newswire / February 26, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL) is making a bold move into the multi-billion-dollar functional mushroom market with the official launch of its Mushroom Powder Capsules-a powerful, all-natural supplement designed to elevate brain function, enhance energy, boost immunity, and optimize overall wellness.
This premium formulation combines five of the most researched and revered medicinal mushrooms:
Lion's Mane - Known for its neuroprotective properties, enhances cognitive function, memory, and focus.
Cordyceps - Increases stamina, improves athletic performance, and supports lung function.
Reishi - Helps reduce stress, promotes better sleep, and strengthens the immune system.
Maitake - Supports metabolic health and helps regulate blood sugar levels.
Turkey Tail - Packed with antioxidants and polysaccharides that fortify gut health and boost immunity.
With scientific studies confirming the vast health benefits of these mushrooms, CBDL is positioning itself at the forefront of the natural health revolution. The global demand for functional mushrooms has skyrocketed due to their ability to combat stress, enhance brain power, and promote longevity-aligning perfectly with consumer trends toward holistic wellness and plant-based supplementation.
A Massive Revenue Opportunity
By launching into the functional mushroom industry, CBDL is tapping into a market projected to exceed $19 billion by 2030, with a CAGR of 9.1%. This strategic expansion will drive substantial new revenue streams and significantly increase consumer engagement with the brand.
CBDL's Mushroom Powder Capsules will be available through its existing sales channels, including direct-to-consumer e-commerce and select retail partners, with further distribution expansion planned as demand grows.
"This launch marks a pivotal moment for CBDL as we expand beyond CBD and into the booming functional mushroom sector," said Lisa Nelson, CEO of CBD Life Sciences Inc. "Our goal is to provide top-tier, science-backed natural solutions that enhance everyday health while capitalizing on one of the fastest-growing wellness trends in the world."
CBDL is committed to aggressive marketing, expanding its direct sales reach, and forming strategic partnerships to position its Mushroom Powder Capsules as a category leader. With consumer interest surging and scientific validation mounting, CBDL's foray into functional mushrooms represents not just an innovative product launch-but a major step toward long-term profitability and market dominance.
Chartmaster
3 semanas hace
CBDL Launches New Mushroom Supplement Drink & Smoothie BarPress Release | 02/19/2025
The functional mushroom industry is exploding, set to surpass $69 billion by 2028, and CBDL is seizing the moment-unlocking a massive revenue opportunity with its latest game-changing expansion.
SCOTTSDALE, ARIZONA / ACCESS Newswire / February 19, 2025 / CBD Life Sciences Inc. (OTC:CBDL) is proud to announce a groundbreaking expansion with the grand opening of its brand-new Mushroom Supplement Drink & Smoothie Bar inside The CBD Vault. This strategic addition marks a significant step forward in the company's mission to diversify its wellness offerings and capitalize on the explosive growth of the functional mushroom industry, projected to surpass $69 billion by 2028.
The grand opening, set to take place in the coming weeks, will introduce an exciting new menu featuring a variety of nutrient-packed shakes and smoothies infused with powerful adaptogenic mushrooms. These drinks will be crafted with premium ingredients, targeting stress reduction, cognitive enhancement, immune support, and overall vitality. Customers will have the convenience of pre-ordering their favorite shakes and smoothies, ensuring quick service and accessibility. Additionally, the smoothie bar will feature seasonal specialty blends, giving customers new and exciting options to try throughout the year.
"The launch of our Mushroom Supplement Drink & Smoothie Bar is a monumental leap for CBDL as we continue to innovate and expand in the wellness industry," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "We are tapping into one of the fastest-growing health trends and giving our customers access to high-quality, science-backed functional mushroom beverages that support both mental and physical well-being."
A Booming Market & Revenue Potential
Functional mushrooms have taken the wellness industry by storm, driven by consumer demand for natural, plant-based health solutions. With research-backed benefits and increasing mainstream adoption, the industry is experiencing rapid year-over-year growth, presenting a lucrative opportunity for CBDL. The adaptogenic and nootropic beverage sector alone is expected to grow exponentially, creating substantial revenue streams and shareholder value.
The Power of Functional Mushroom Beverages
The Mushroom Supplement Drink & Smoothie Bar at The CBD Vault will feature carefully formulated beverages incorporating reishi, lion's mane, chaga, cordyceps, and ashwagandha, all known for their exceptional health benefits. From enhancing cognitive function and memory to reducing stress, boosting immunity, and supporting gut health, these smoothies and shakes will cater to consumers looking for delicious yet effective wellness solutions. The bar will also offer customization options, allowing customers to add extra boosters such as collagen, CBD, or plant-based proteins to personalize their drinks.
A Major Step Forward for CBDL
The addition of the Mushroom Supplement Drink & Smoothie Bar strengthens CBDL's position as a trailblazer in the holistic health and wellness sector. With The CBD Vault already a staple for high-quality CBD products, this expansion allows the company to appeal to a broader audience, attracting health-conscious consumers, athletes, and professionals looking for cutting-edge nutritional options. CBDL's move into the functional beverage space further enhances its competitive advantage and brand visibility within the thriving wellness market.
Join Us for the Grand Opening!
CBDL invites investors, customers, and the community to celebrate this exciting new venture at The CBD Vault's grand opening event for the Mushroom Supplement Drink & Smoothie Bar. More details will be announced soon, but attendees can expect exclusive promotions, sample tastings, and insights into the future of functional wellness.
As CBD Life Sciences Inc. continues to evolve, this latest expansion signals a strong commitment to growth, innovation, and maximizing shareholder value. By embracing the functional mushroom movement, CBDL is positioning itself at the forefront of a multi-billion-dollar industry, setting the stage for continued success and profitability.
About CBD Life Sciences Inc. (CBDL)
CBD Life Sciences Inc. (OTC:CBDL) is a leading innovator in the CBD and wellness sector, committed to delivering premium, science-backed CBD products designed to enhance health, performance, and overall well-being. With an ever-expanding product portfolio and aggressive market expansion strategy, CBDL is shaping the future of CBD retail, both online and in major marketplaces nationwide.
For more information about CBD Life Sciences, Inc. and its product offerings, visit www.thecbdvault.com
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com
Stay Connected & Be the First to Try Our New Functional Mushroom Products!
Mushroom Madness Instagram: https://www.instagram.com/mushroom.madnessaz
Mushroom Madness Website: https://www.mushroommadness.shop
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contact Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720
SOURCE: CBD Life Sciences, Inc.
Related Images
View the original press release on ACCESS Newswire
https://www.otcmarkets.com/stock/CBDL/news/CBDL-Launches-New-Mushroom-Supplement-Drink--Smoothie-Bar?id=468080
AveragePenny
3 semanas hace
$CBDL CBDL Launches New Mushroom Supplement Drink & Smoothie Bar
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cbdl-launches-new-mushroom-supplement-drink-and-smoothie-bar-987273
The functional mushroom industry is exploding, set to surpass $69 billion by 2028, and CBDL is seizing the moment-unlocking a massive revenue opportunity with its latest game-changing expansion.
SCOTTSDALE, ARIZONA / ACCESS Newswire / February 19, 2025 / CBD Life Sciences Inc. (OTC:CBDL) is proud to announce a groundbreaking expansion with the grand opening of its brand-new Mushroom Supplement Drink & Smoothie Bar inside The CBD Vault. This strategic addition marks a significant step forward in the company's mission to diversify its wellness offerings and capitalize on the explosive growth of the functional mushroom industry, projected to surpass $69 billion by 2028.
The grand opening, set to take place in the coming weeks, will introduce an exciting new menu featuring a variety of nutrient-packed shakes and smoothies infused with powerful adaptogenic mushrooms. These drinks will be crafted with premium ingredients, targeting stress reduction, cognitive enhancement, immune support, and overall vitality. Customers will have the convenience of pre-ordering their favorite shakes and smoothies, ensuring quick service and accessibility. Additionally, the smoothie bar will feature seasonal specialty blends, giving customers new and exciting options to try throughout the year.
"The launch of our Mushroom Supplement Drink & Smoothie Bar is a monumental leap for CBDL as we continue to innovate and expand in the wellness industry," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "We are tapping into one of the fastest-growing health trends and giving our customers access to high-quality, science-backed functional mushroom beverages that support both mental and physical well-being."
A Booming Market & Revenue Potential
Functional mushrooms have taken the wellness industry by storm, driven by consumer demand for natural, plant-based health solutions. With research-backed benefits and increasing mainstream adoption, the industry is experiencing rapid year-over-year growth, presenting a lucrative opportunity for CBDL. The adaptogenic and nootropic beverage sector alone is expected to grow exponentially, creating substantial revenue streams and shareholder value.
The Power of Functional Mushroom Beverages
The Mushroom Supplement Drink & Smoothie Bar at The CBD Vault will feature carefully formulated beverages incorporating reishi, lion's mane, chaga, cordyceps, and ashwagandha, all known for their exceptional health benefits. From enhancing cognitive function and memory to reducing stress, boosting immunity, and supporting gut health, these smoothies and shakes will cater to consumers looking for delicious yet effective wellness solutions. The bar will also offer customization options, allowing customers to add extra boosters such as collagen, CBD, or plant-based proteins to personalize their drinks.
A Major Step Forward for CBDL
The addition of the Mushroom Supplement Drink & Smoothie Bar strengthens CBDL's position as a trailblazer in the holistic health and wellness sector. With The CBD Vault already a staple for high-quality CBD products, this expansion allows the company to appeal to a broader audience, attracting health-conscious consumers, athletes, and professionals looking for cutting-edge nutritional options. CBDL's move into the functional beverage space further enhances its competitive advantage and brand visibility within the thriving wellness market.
Join Us for the Grand Opening!
CBDL invites investors, customers, and the community to celebrate this exciting new venture at The CBD Vault's grand opening event for the Mushroom Supplement Drink & Smoothie Bar. More details will be announced soon, but attendees can expect exclusive promotions, sample tastings, and insights into the future of functional wellness.
As CBD Life Sciences Inc. continues to evolve, this latest expansion signals a strong commitment to growth, innovation, and maximizing shareholder value. By embracing the functional mushroom movement, CBDL is positioning itself at the forefront of a multi-billion-dollar industry, setting the stage for continued success and profitability.
Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
RedSox04
2 semanas hace
TrendTrade2016
3 semanas hace
Monroe1
3 semanas hace
Hot Features
Premium
